Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Derek Archila, an analyst from Wells Fargo, maintained the Buy rating on ACELYRIN, INC. (SLRN – Research Report). The associated price target ...

A statewide grand jury convened at the request of Florida Gov. Ron DeSantis has found no evidence of criminal activity ...

Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.

A Phase 1 trial testing RAG-17, a potential ALS therapy for people carrying SOD1 mutations, has dosed its first participant.

Avenzo to receive exclusive global license (excluding Greater China) for development, manufacturing and commercialization of potential best-in-class EGFR/HER3 antibody-drug conjugate SAN DIEGO, ...

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today ...

The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ...

A new book offers feedback from experts on the state of schizophrenia treatment and research, with new perspectives and ...

Personal Growth - thin line vector icon set. Pixel perfect. Editable stroke. The set contains icons: Leadership, Learning, Career, Skill, Motivation, Moving Up ...

Windows has upped its aesthetic quotient with every newer version. The user interface and the accompanying icons have improved, keeping in line with the latest designs. Even then, seeing the same ...